Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 3/20 | 0.53 |
| ▸ | SLC9A3 | P48764 | 1/20 | 0.53 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.53 |
| ▸ | HTR2B | P41595 | 11/20 | 0.46 |
| ▸ | HTR7 | P34969 | 9/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | HTR2A | P28223 | 1/20 | 0.43 |
| ▸ | HTR2C | P28335 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27401335 | 0.92 | SLC9A1 (0.59) | SLC9A1SLC9A3SLC9A2 | |
| SCHEMBL7822660 | 0.92 | SLC9A1 (0.59) | SLC9A1SLC9A3SLC9A2 | |
| SCHEMBL8699872 | 0.84 | SLC9A1 (0.43) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL7825554 | 0.84 | SLC9A1 (0.55) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| Hydrochloric Acid SCHEMBL7825501 | 0.82 | SLC9A1 (0.54) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL1388036 | 0.81 | HTR2B (0.46) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL7825774 | 0.81 | LMNA (0.57) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL7824138 | 0.80 | PDE4A (0.46) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL8707718 | 0.80 | SLC9A1 (0.49) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 | |
| SCHEMBL7823135 | 0.76 | SLC9A1 (0.40) | SLC9A1SLC9A3SLC9A2HTR2BHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1080257-C | Guanidine derivatives as inhibitors of Na+/H+ exchange in cells | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-03-06 | — | — | CN | disclosed |
| EP-0699185-B1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-09-05 | — | — | EP | disclosed |
| US-5824691-A | CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-20 | — | — | US | disclosed |
| CN-1123545-A | Guanidine derivatives as inhibitors of Na+/H+ exchange in cells | FUJISAWA PHARMACEUTICAL CO (JP) | 1996-05-29 | — | — | CN | disclosed |
| EP-0699185-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+ /H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994026709-A1 | GUANIDINE DERIVATIVES AS INHIBITORS OF Na+/H+ EXCHANGE IN CELLS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-24 | — | — | WO | disclosed |